Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018.
Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures and Danaher’s acquisition of Cepheid are among the specific deals discussed in the report.
The report also details acquisitions driven by the development of cutting-edge technologies such as gene editing, liquid biopsy, microbiome research, and next-generation sequencing.
Gene Editing
Liquid Biopsy
Microbiome
Next-Generation Sequencing
Automation, and the Introduction of New, Large, Automated Platforms
Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests
Connectivity
Looking to the East
- Executive Summary
- The Market Landscape
- Roche
- Abbott/Alere
- Siemens
- Beckman Coulter, Inc. / Danaher
- The Changing Landscape
- Market Trends Helping to Drive Mergers and Acquisitions
- Gene Editing
- Liquid Biopsy
- Next-Generation Sequencing
- Automation, and the Introduction of New, Large, Automated Platforms
- Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests
- Connectivity
- Looking to the East
- Microbiome
- Methodology
- The Market Landscape
- IVD Mergers and Acquisitions
- Overview: The IVD Industry – A Changing Market
- M&A in Selected Markets
- Lab-Developed Test (LDT) Services Market
- The PCR/NAAT Market
- Table Selected Acquisitions of Diagnostic Companies, from 2017 to mid-March 2018
- Selected 2017 / 2018 Acquisitions of Note
- Abbott: Acquisitions, Divestures and the Alere Deal
- Siemens' Divestiture of a Portion of Its Healthcare Business, Siemens Healthineers
- Roche Active in M&A, Part 1
- Celgene Active in Early 2018
- Agilent Makes Cell Analysis Buy
- Charles River Labs Acquires KWS BioTest
- Early 2018 M&A Activity in Biotech -- Sanofi Buys Bioverativ, Ablynx
- Chembio Diagnostics Acquires Malaysian Firm RVR Diagnostics
- Konica Minolta Acquires Ambry Genetics
- Quidel Amends Alere Deal
- Thermo Completes Patheon Acquisition
- Agilent Acquires the Molecular and Sample Barcoding Patent Portfolios of Population Genetics
- Enterome and Nestle Health Science Form Microbiome Diagnostics Partners
- PerkinElmer Expansion via Tulip and Euroimmun Acquisitions
- Sysmex Acquires Oxford Gene Technology (OGT)
- LabCorp Completes PAML Acquisition
- Cathay Fortune International Acquires Molecular Diagnostics Firm Epigenomics
- Bio-Rad Acquires ddPCR Developer RainDance
- QIAGEN M&A Activity
- Agilent Completes the Acquisition of Multiplicom
- Grifols Acquires NAT Donor Screening Unit from Hologic
- Johnson & Johnson Diabetes Business Attracts Chinese Interest
- The 2015-2016 Market
- Table Selected Acquisitions of Diagnostic Companies, 2015-2016
- Selected 2015 / 2016 Acquisitions of Note
- Roche Active in M&A, Part 2
- Danaher's Acquires Molecular Diagnostics Leader Cepheid for Nearly $4 Billion
- Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
- Thermo Fisher Scientific Completes Major Deals in 2016
- Beckman Coulter Acquires Siemens Healthcare Diagnostics' Clinical Microbiology Business
- Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular Research Acquisition
- Founding CTC Technology Finds Another Home
- Curetis Acquires Real-Time qPCR-based Gyronimo Platform from Carpegen GmbH and Systec GmbH
- Bruker Acquires Nucleic Acid Testing Assays and Syndromic Panel Technology
- LabCorp Completes Its Acquisition of Sequenom
- Curetis Acquires Asset from Siemens Technology Accelerator
- Debiopharm Group Acquires GenePOC
- Luminex Seeks to Leverage Nanosphere's Verigene Platform
- Siemens Expands Its Diagnostics Portfolio
- Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal
- Immucor Acquires Sirona Genomics
- llumina Establishes GRAIL Bio
- Charles River Acquires Agilux, WIL Research, and Oncotest
- IBM Healthcare/Watson Continues Expansion
- BD Acquires CareFusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook